Levels of the enzyme PRDX2 increase as a protective response in chronic thromboembolic pulmonary hypertension (CTEPH) and help reduce…
Articles by Margarida Maia, PhD
Women with pulmonary hypertension have a lower risk of death than men, a difference that persists regardless of how…
Uptravi (selexipag) may reduce blood pressure in the lungs of children with pulmonary arterial hypertension (PAH) and help…
From 1990 to 2021, cases of pulmonary arterial hypertension (PAH) increased worldwide among older adults, mainly due to growing…
Stanford University has been awarded a grant from the U.S. National Institutes of Health (NIH) to begin a Phase 2…
A 5-year-old boy with a neuroblastoma developed pulmonary arterial hypertension (PAH) after receiving high-dose busulfan to prepare for a…
Exosomes — very small, sac-like structures — derived from stem cells may offer a potential treatment for hypoxic pulmonary…
Elevated blood levels of a protein called CTRP7 — which are significantly higher in people with pulmonary arterial hypertension…
Researchers used small particles called extracellular vesicles to deliver a form of apelin directly to damaged blood vessels in the…
Nearly two-thirds of patients with left ventricular diastolic dysfunction (LVDD) — in which the heart struggles to relax and fill…
Combining pulmonary vasodilators, medications that widen blood vessels, and antifibrotics, which slow the progression of scarring, may prolong survival and…
Heart failure related to pulmonary arterial hypertension (PAH) is becoming more common, with patients living fewer years in full…